---
layout: default
title: People
nav_order: 8
last_modified_date: 2022-03-28
---

<!---

# Title

## Multiplexed and reproducible high content screening of live and fixed cells using the Dye Drop method

# Abstract

High throughput measurement of cell perturbation, by libraries of small molecules or gene knockouts, is a key step in functional genomics and pre-clinical drug development. However, it is difficult to perform viable, single-cell assays in 384-well plates, limiting many studies to simple well-average measurements (e.g. CellTiter-Glo®). Here we describe a public domain “Dye Drop” method in which sequential density displacement is used to perform multi-step assays for cell viability and EdU incorporation followed by immunofluorescence imaging. The method is rapid, reproducible, can be readily customized, and is compatible with either manual or automated laboratory equipment. We demonstrate Dye Drop in the collection of dose-response data for 67 drugs in 58 breast cancer cell lines and separate cytostatic and cytotoxic responses, thereby providing new insight into the effects of specific drugs on cell cycle progression and cell viability. Dye Drop substantially improves the tradeoff between data content and cost, enabling collection of large information-rich datasets.


# Graphical Abstract

<img src="{{ site.baseurl }}/assets/images/dye_drop/graphical_abstract.png" class="center">

\\# Key findings


# Publication Information

*Multiplexed and reproducible high content screening of live and fixed cells using the Dye Drop method.* Caitlin E. Mills<sup>1\*</sup>, Kartik Subramanian<sup>1,2\*</sup>, Marc Hafner<sup>1,3\*</sup>, Mario Niepel<sup>1,4</sup>, Luca Gerosa<sup>1,3</sup>, Mirra Chung<sup>1</sup>, Chiara Victor<sup>1</sup>, Ben Gaudio<sup>1</sup>, Clarence Yapp<sup>1</sup>, Peter K. Sorger<sup>1</sup>

\* These authors contributed equally

1 Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA 02115

2 Current address: Bristol Myers Squibb, Cambridge, MA 02142

3 Current address: Genentech, Inc., South San Francisco, CA 94080

4 Current address: Ribon Therapeutics, Inc., Cambridge, MA 02140

__Corresponding Author__: peter_sorger@hms.harvard.edu

DOI: 10.1101/2021.08.27.457854
PMID:

[BioRxiv](https://doi.org/10.1101/2021.08.27.457854){: .btn .btn-green .mr-4 }{:target="_blank"}{:rel="noopener noreferrer"}
--->

# People

## Lead Developers
* [Caitlin E. Mills](https://scholar.harvard.edu/caitlinmills/bio){:target="_blank"}
* [Kartik Subramanian](https://scholar.harvard.edu/skartik/biography){:target="_blank"}
* [Marc Hafner](https://sites.google.com/view/marchafner){:target="_blank"}

## Contributors
* [Mario Niepel](https://sorger.med.harvard.edu/people/mario-niepel/){:target="_blank"}
* [Luca Gerosa](https://scholar.harvard.edu/gerosa){:target="_blank"}
* [Mirra Chung](https://scholar.harvard.edu/mchung/project-information){:target="_blank"}
* [Chiara Victor](https://scholar.harvard.edu/chiara/home){:target="_blank"}
* [Ben Gaudio](https://scholar.harvard.edu/bengaudio/home){:target="_blank"}
* [Clarence Yapp](https://scholar.harvard.edu/clarence/who-clarence){:target="_blank"}

## Website Contributors
* [Juliann Tefft](https://www.linkedin.com/in/juliann-tefft){:target="_blank"}
* [Han Xu](https://www.linkedin.com/in/han-xu-16a0216b/){:target="_blank"}
* [Nicholas Clark](https://github.com/NicholasClark/){:target="_blank"}

## Laboratory Principal Investigator(s):
* [Peter K. Sorger](https://scholar.google.com/citations?user=wS6Ii_cAAAAJ&hl=en){:target="_blank"}